Orgenesis Inc

ORGS NASDAQ
4.440
-0.110
-2.42%
Closed 16:00 08/23 EDT
Open
4.470
Prev Close
4.550
High
4.540
Low
4.372
Volume
4.19K
Avg Vol (3M)
24.36K
52 Week High
9.25
52 Week Low
3.780
% Turnover
0.03%
Market Cap
71.67M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Orgenesis Inc ORGS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.
MORE >

Recently

Name
Price
%Change